Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1984-12-26
|
pubmed:language |
ita
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0009-9074
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
30
|
pubmed:volume |
110
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
521-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:6238766-Amikacin,
pubmed-meshheading:6238766-Cefoperazone,
pubmed-meshheading:6238766-Drug Synergism,
pubmed-meshheading:6238766-Escherichia coli Infections,
pubmed-meshheading:6238766-Humans,
pubmed-meshheading:6238766-Meningitis,
pubmed-meshheading:6238766-Pseudomonas Infections,
pubmed-meshheading:6238766-Urinary Tract Infections
|
pubmed:year |
1984
|
pubmed:articleTitle |
[Our experience with sodium cefoperazone].
|
pubmed:publicationType |
Journal Article,
English Abstract
|